Renal Cancer
Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example - Abstract
July 11, 2014
ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma - Abstract
July 11, 2014
Factors involved in treatment preference in patients with renal cancer: Pazopanib versus sunitinib - Abstract
July 10, 2014